- No FAQs found
- ABL Kinase Domain Mutation in CML, Cell-based
- ABO Group and Rh Type
- Acid-Fast Bacillus (AFB) Identification, Sequencing and Stain, Paraffin Block
- ADAMTS13 Activity with Reflex to ADAMTS13 Inhibitor
- Alcohol Metabolites, Quantitative, Urine
- Alpha-Globin Common Mutation Analysis
- Alpha-Globin Gene Deletion or Duplication
- Alpha-Globin Gene Sequencing
- Anti-Müllerian Hormone AssessR™
- Anti-PF4 and Serotonin Release Assay (SRA) for Diagnosing Heparin-induced Thrombocytopenia/Thrombosis (HIT/HITT)
- Antiphospholipid Antibodies
- ASCVD Risk Panel with Score
- Autoimmune Epilepsy Evaluation
- Autoimmune Diseases, Tests for
- B-cell and T-cell Clonality Assays by PCR
- B-Type Natriuretic Peptide (BNP)
- BCR-ABL1 Gene Rearrangement, Quantitative PCR
- Beta-Globin Complete
- Biotin: Interference with Laboratory Assays
- BRCAvantage®, Ashkenazi Jewish Screen
- BRCAvantage®, Rearrangements
- BRCAvantage™, Comprehensive
- BRCAvantage™, Single Site
- CDH1 Sequencing and Deletion/Duplication
- Clostridium difficile Diagnostic Testing
- C1 Inhibitor, Protein and Functional Tests
- Calreticulin (CALR) Mutation Analysis
- Carbapenem Resistant Enterobacteriaceae Culture Screen
- Cardio IQ Lipoprotein Fractionation, Ion Mobility
- CardioIQ® Insulin Resistance Panel with Score
- Cervical Cancer, TERC, FISH
- CFvantage® Cystic Fibrosis Expanded Screen
- Chlamydia trachomatis, TMA
- Chlamydia trachomatis/Neisseria gonorrhoeae RNA, TMA
- Chromosomal Microarray, POC, ClariSure®, Oligo-SNP
- Chromosomal Microarray, Postnatal, ClariSure® Oligo-SNP
- Chromosome Analysis and AFP with Reflex to AChE, Fetal Hgb, Amniotic Fluid
- Chromosome Analysis, Amniotic Fluid
- Chromosome Analysis, Blood
- Chromosome Analysis, Blood with Reflex to Postnatal, ClariSure® Oligo-SNP Array
- Chromosome Analysis, Chorionic Villus Sample
- Chromosome Analysis, High Resolution
- Chromosome Analysis, High Resolution with Reflex to Postnatal, ClariSure® Oligo-SNP Array
- Chromosome Analysis, Mosaicism
- Chromosome Analysis, Neonatal Blood
- Chromosome Analysis, Sister Chromatid Exchange
- Chromosome Analysis, Tissue
- Chromosome DEB Assay for Fanconi anemia
- Chronic Lymphocytic Leukemia (CLL) - Diagnostic and Prognostic Testing
- Culture, Fungus
- Culture, Urine, Routine
- Cystic Fibrosis Screen
- Cytomegalovirus (CMV) and Epstein Barr Virus (EBV) PCR
- D-Dimer, Quantitative
- Dementia, Secondary Causes
- Dengue Virus Testing
- Diabetes Risk Panel with Score and Cardio IQ® Diabetes Risk Panel with Score
- Diagnosis of Intestinal Parasites
- Drug Testing, General Toxicology (Blood, Urine, or Serum)
- Drug Toxicology Alcohol Metabolite, with Confirmation, Oral Fluid
- Drug Toxicology Monitoring, Oral Fluid Testing
- Factor V (Leiden) Mutation Analysis
- Familial Hypercholesterolemia (FH) Panel
- Familial Hypercholesterolemia (FH) Single Site
- Familial Mediterranean Fever Mutation Analysis
- First Trimester Screen, hCG
- First Trimester Screen, Hyperglycosylated hCG (h-hCG)
- FISH, Angelman
- FISH, MET Amplification
- FISH, Myeloma, 17p-, rea 14q32 with Reflexes
- FISH, Prader-Willi
- FISH, Prenatal Screen
- No FAQs found
- Helicobacter pylori (H pylori) Antibody Discontinuation
- Heparin, Anti-Xa
- Hepatitis B Surface Antibody, Quantitative
- Hepatitis B Surface Antigen, Quantitative, Monitoring
- Hepatitis C Antibody with Reflex to HCV RNA, PCR with Reflex to Genotype
- Hepatitis C Viral RNA Genotype 1 NS5A Drug-resistance
- Hepatitis C Viral RNA Genotype 3 NS5A Drug Resistance
- Hepatitis C Viral RNA NS3 Drug Resistance
- Hepatitis C Viral RNA, Genotype, LiPA
- Hepatitis C Virus Antibody and RNA Testing
- Hereditary Cancer Panels: MYvantageTM Hereditary Comprehensive Cancer Panel and GIvantageTM Hereditary Colorectal Cancer Panel
- Hereditary Hemochromatosis DNA Mutation Analysis
- Herpes Simplex Virus (HSV) Type-Specific IgG Antibodies
- Herpes Simplex Virus Type 2 (HSV-2) IgG Inhibition, ELISA
- HIV-1 Coreceptor Tropism, Proviral DNA
- HIV-1 Coreceptor Tropism, Ultradeep Sequencing
- HIV-1 Integrase Genotype
- HIV-1 Resistance, Proviral DNA (RTI, PI, Integrase Inhibitors)
- HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexes
- HPV mRNA E6/E7
- Infliximab and Adalimumab Drug and Anti-drug Antibody Testing
- Influenza A and B Antigen, Immunoassay
- Influenza Type A and B Antibodies
- Insulin, Intact, LC/MS/MS
- Integrated Screen, Part 1
- Integrated Screen, Part 2
- Intrinsic Factor Blocking Antibody
- No FAQs found
- No FAQs found
- Maternal Serum AFP
- Melanoma, BRAF V600E and V600K Mutation Analysis, THxID®
- Metanephrines, Fractionated, Free, LC/MS/MS, Plasma
- Methylenetetrahydrofolate Reductase (MTHFR), DNA Analysis
- Microalbumin (Urinary Albumin Excretion)
- Pain Management and CYP2D6/CYP2C19
- Pain Management Antidepressants, With Confirmation, Urine
- Pain Management Antipsychotics, With Confirmation, Serum and Urine
- Pain Management, Naltrexone, Quantitative, Urine
- Partial Thromboplastin Time, Activated (aPTT)
- Penta Screen
- PIK3CA Mutation Analysis
- Platelet Antibody Screen (Indirect)
- PNH with FLAER (High Sensitivity)
- Prothrombin Time with INR
- PTH, Intact and Calcium
- Streptococcus pneumoniae (Pneumococcal) Antibody Tests
- Saccharomyces cerevisiae Antibodies (ASCA) (IgG, IgA)
- Sequential Integrated Screen, Part 1
- Sequential Integrated Screen, Part 2
- Serum Integrated Screen, Part 1
- Serum Integrated Screen, Part 2
- Serum Pregnancy Tests
- Sickle Cell Screen
- Stepwise, Part 1
- Stepwise, Part 2
- SureSwab® Trichomonas vaginalis RNA, Qualitative TMA
- SureSwab®, Candidiasis, PCR
- TP53 Sequencing and Deletion/Duplication
- T4, Free
- Tamoxifen and Metabolites, LC-MS/MS
- Testosterone Testing
- Total Testosterone, LC/MS/MS
- Triple Screen
- No FAQs found
- No FAQs found
- No FAQs found
Drug Toxicology Monitoring, Oral Fluid TestingTest code(s) 36862, 93975, 93976, 93977, 93978, 93979, 93980, 93981, 93982, 93983, 93984, 93974, 93985, 93986, 93987, 93988, 93990
Question 1. What is oral fluid?
Oral fluid is the liquid material collected from within the oral cavity of the mouth and is comprised of saliva (from submandibular, sublingual, and parotid glands), gingival crevicular fluid (from between teeth and gums), cellular debris, bacteria, and food residues.
Question 2. What is oral fluid drug testing?
Oral fluid drug testing is an alternative to urine drug testing. Results are similar to those obtained from urine drug testing, but there are several important differences. First, drugs are detectable sooner in oral fluid than in urine. Drugs enter the bloodstream and are transported throughout the body. Once the blood reaches the salivary glands, drugs rapidly enter the oral fluid. This takes less time than the time taken for drugs to enter urine. Second, drugs are cleared from oral fluid faster than they are cleared from urine. Thus, the oral fluid “detection window” for some drugs such as cocaine and heroin can be as little as a few hours. However, most drugs remain detectable in oral fluid for 24 to 50 hours after ingestion.1
Question 3. Which tests are available for oral fluid testing?
Quest Diagnostics offers multiple options for oral fluid drug testing. These include:
- Multi-class drug panels for presumptive analysis with reflex to definitive confirmation and quantitation
- Single-class drug tests for presumptive analysis with reflex to definitive confirmation and quantitation
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is used for both the presumptive analysis and the definitive confirmation and quantitation.
Drugs classes and compounds and assay cutoffs for detection are listed in the table that can be accesses here.
Question 4. Why test using oral fluid?
Drug testing in the clinical setting can provide information that improves patient care. The results of drug testing can often prompt important clinical discussions with patients. For example, absence of an expected drug could suggest poor adherence or diversion, whereas detection of a non-prescribed licit or illicit drug could raise concerns regarding substance misuse. Discrepancies between expected and actual results could also call attention to patient intolerance to medication side effect or potential medical factors affecting drug disposition.
Various sample types can be used for drug testing. Urine is the most widely used and well-established sample type at present and offers the broadest options for drug testing. However, urine-based drug testing has several potential drawbacks including inconvenience and patient embarrassment, sample integrity problems when collection is not observed, and lack of privacy when specimen collection must be observed.
The decision to use oral fluid drug testing should take into account the potential benefits and drawbacks of this matrix as they apply to individual clinical scenarios. The main advantage of oral fluid testing is the ease of observing sample collection, while the disadvantages relate to shorter drug detection windows, lower drug concentrations in the sample, and limited specimen volume.
Question 5. What are the specimen collection and rejection criteria for oral fluid testing?
The preferred specimen is 3 mL of random oral fluid collected in an Oral-Eze® collection device.
Specimen stability is:
- Room temperature: 72 hours
- Refrigerated temperature: 7 days
- Frozen temperature: 30 days
Rejection criteria: Specimen submitted in a non-Oral-Eze® collection device.
Question 6. What does the test result mean?
Negative results indicate absence of drug and/or metabolite or concentrations below the assay cutoff. Positive results indicate presence of the respective drug and/or metabolite. Detection of drug(s) or drug metabolite(s) suggests that the patient has taken the drug(s).
There is no correlation between the time of dose, the dose taken, and the concentration of drug and/or metabolite in the oral fluid.
Question 7. Can specimens for oral fluid testing be sent in the same bag with other clinical specimens?
Yes. Oral fluid drug testing is considered a clinical test; therefore, multiple clinical specimens from one patient may be placed in the same bag. However, specimens from another patient should be placed in a different bag.
Question 8. Whom should a client call with questions about this test?
If you have any questions regarding this information or require assistance with interpreting these drug test results, please contact a Quest Diagnostics toxicology specialist at 1-877-40-RX TOX (1-877-407-9869). Specialists are available to assist you Monday through Friday from 8am to 10pm ET.
- Verstraete AG. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit. 2004;26:200-205.